Hims & Hers Health Inc.(HIMS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

HIMS Hims & Hers Health Inc.

Market Closed 07-11 16:00:00 EDT

47.89

-2.38

-4.73%

盘后48.07

+0.18+0.38%

19:59 EDT

High50.77	Low47.76	Vol19.00M
Open50.10	D1 Closing50.27	Amplitude5.99%
Mkt Cap10.72B	Tradable Cap9.32B	Total Shares223.83M
T/O933.28M	T/O Rate9.77%	Tradable Shares194.54M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"HIMS","market":"US","secType":"STK","nameCN":"Hims & Hers Health Inc.","latestPrice":47.89,"timestamp":1752264000000,"preClose":50.27,"halted":0,"volume":19001007,"hourTrading":{"tag":"盘后","latestPrice":48.07,"preClose":47.89,"latestTime":"19:59 EDT","volume":643685,"amount":30856167.1193,"timestamp":1752278399991},"delay":0,"floatShares":194537034,"shares":223831522,"eps":0.681796,"marketStatus":"Market Closed","change":-2.38,"latestTime":"07-11 16:00:00 EDT","open":50.1,"high":50.77,"low":47.7603,"amount":933277249.072764,"amplitude":0.059871,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.681796,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1752480000000},"marketStatusCode":7,"adr":0,"exchange":"NYSE","adjPreClose":50.27,"preHourTrading":{"tag":"盘前","latestPrice":50.05,"preClose":50.27,"latestTime":"09:29 EDT","volume":319679,"amount":15951684.798530001,"timestamp":1752240592072},"postHourTrading":{"tag":"盘后","latestPrice":48.07,"preClose":47.89,"latestTime":"19:59 EDT","volume":643685,"amount":30856167.1193,"timestamp":1752278399991},"volumeRatio":0.6975811398332492,"optionData":{"bulkOrders":[{"symbol":"HIMS","call":true,"expireDate":1755230400000,"strike":"65.0","timestamp":1752244803480,"price":2.14,"volume":2500,"amount":535000,"type":"+"},{"symbol":"HIMS","call":true,"expireDate":1755230400000,"strike":"60.0","timestamp":1752244803479,"price":3.17,"volume":2500,"amount":792500,"type":"+"}]},"impliedVol":1.1107,"impliedVolPercentile":0.652},"requestUrl":"/m/hq/s/HIMS","defaultTab":"news","newsList":[{"id":"2550647764","title":"PRESS DIGEST-Canada - July 10","url":"https://stock-news.laohu8.com/highlight/detail?id=2550647764","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550647764?lang=en_us&edition=full_marsco","pubTime":"2025-07-10 20:05","pubTimestamp":1752149107,"startTime":"0","endTime":"0","summary":"PRESS DIGEST-Canada - July 10 July 10 (Reuters) - The following are the top stories from selected Canadian newspapers. Reuters has not verified these stories and does not vouch for their accuracy.THE ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250710:nL4N3T70YD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMS","BK4196"],"gpt_icon":1},{"id":"2550570096","title":"Citi Remains a Sell on Hims & Hers Health (HIMS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2550570096","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550570096?lang=en_us&edition=full_marsco","pubTime":"2025-07-10 02:05","pubTimestamp":1752084318,"startTime":"0","endTime":"0","summary":"In a report released today, Daniel Grosslight from Citi reiterated a Sell rating on Hims & Hers Health, with a price target of $30.00. The company’...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/citi-remains-a-sell-on-hims-hers-health-hims-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/citi-remains-a-sell-on-hims-hers-health-hims-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4196","HIMS"],"gpt_icon":0},{"id":"2550657041","title":"Leerink Partners Remains a Hold on Hims & Hers Health (HIMS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2550657041","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550657041?lang=en_us&edition=full_marsco","pubTime":"2025-07-10 02:05","pubTimestamp":1752084315,"startTime":"0","endTime":"0","summary":"Leerink Partners analyst Michael Cherny reiterated a Hold rating on Hims & Hers Health today and set a price target of $42.00. The company’s shares...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/leerink-partners-remains-a-hold-on-hims-hers-health-hims-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/leerink-partners-remains-a-hold-on-hims-hers-health-hims-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4196","HIMS"],"gpt_icon":0},{"id":"2550655658","title":"Hims & Hers Times Pivot to Canada With Generic Weight-Loss Drug After Wegovy Fallout -- Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2550655658","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550655658?lang=en_us&edition=full_marsco","pubTime":"2025-07-09 22:10","pubTimestamp":1752070200,"startTime":"0","endTime":"0","summary":"Hims & Hers Health is planning an entry into the Canadian market next year, timing it with the new availability of a generic weight loss drug a month after losing rights to sell Novo Nordisk's branded version.The digital health and wellness platform said Wednesday that it plans to enter the country in 2026 and offer access to lower-cost treatment options through its digital platform, including the generic weight loss drug semaglutide.The move follows a dramatic breakup in June between Hims & Hers and Danish drug maker Novo Nordisk, which makes the brand name weight loss drug Wegovy. Novo Nordisk accused the Hims & Hers of illegally selling cheaper copycats of its own weight-loss drug and engaging in deceptive marketing.The availability of the generic semaglutide means that the virtually identical drug as the branded version can be offered at much lower prices.The two companies had only two months prior unveiled what they had called a long-term collaboration to directly provide Wegovy t","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","HIMS"],"gpt_icon":1},{"id":"1153296374","title":"Stock Track | Hims & Hers Health Soars 5.63% on Planned Canadian Expansion and Generic Semaglutide Launch","url":"https://stock-news.laohu8.com/highlight/detail?id=1153296374","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153296374?lang=en_us&edition=full_marsco","pubTime":"2025-07-09 21:35","pubTimestamp":1752068112,"startTime":"0","endTime":"0","summary":"Hims & Hers Health Inc. (HIMS) saw its stock soar 5.63% in Wednesday's trading session following the company's announcement of its planned expansion into Canada in 2026. The digital health and...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["HIMS"],"gpt_icon":1},{"id":"2550630102","title":"Hims & Hers Health Plans 2026 Canada Expansion with Generic Semaglutide Launch","url":"https://stock-news.laohu8.com/highlight/detail?id=2550630102","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550630102?lang=en_us&edition=full_marsco","pubTime":"2025-07-09 21:27","pubTimestamp":1752067651,"startTime":"0","endTime":"0","summary":"Hims & Hers Health Inc., a leading digital health and wellness platform, has announced its plans to expand into Canada by 2026. This expansion will coincide with the anticipated availability of generic semaglutide, marking the first time this weight loss medication will be accessible in generic form globally. The move is part of Hims & Hers' strategy to provide affordable, holistic obesity treatments and enhance access to healthcare. Following its acquisition of ZAVA, a digital health pioneer in Europe, the company aims to leverage this entry into the Canadian market to demonstrate the potential of high-quality, accessible weight loss care.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hims & Hers Health Inc. published the original co","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250709:nNDL6FFZwM:1","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Hims & Hers Health Plans 2026 Canada Expansion with Generic Semaglutide Launch","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMS","BK4196"],"gpt_icon":0},{"id":"2550463015","title":"Hims & Hers Announces Planned 2026 Expansion to Canada, Following Zava Acquisition Completion","url":"https://stock-news.laohu8.com/highlight/detail?id=2550463015","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550463015?lang=en_us&edition=full_marsco","pubTime":"2025-07-09 21:00","pubTimestamp":1752066002,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250709:nTUAHGWYK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4196","HIMS"],"gpt_icon":0},{"id":"2550731965","title":"CFO Oluyemi Okupe Reports Disposal of Common Shares in Hims & Hers Health Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2550731965","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550731965?lang=en_us&edition=full_marsco","pubTime":"2025-07-09 04:41","pubTimestamp":1752007267,"startTime":"0","endTime":"0","summary":"Oluyemi Okupe, Chief Financial Officer of Hims & Hers Health Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hims & Hers Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on July 08, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250708:nNDLbfP876:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","HIMS"],"gpt_icon":1},{"id":"2550527946","title":"Morgan Stanley Weighs In on HIMS Stock Amid Ongoing Legal and Regulatory Hurdles","url":"https://stock-news.laohu8.com/highlight/detail?id=2550527946","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550527946?lang=en_us&edition=full_marsco","pubTime":"2025-07-09 02:19","pubTimestamp":1751998764,"startTime":"0","endTime":"0","summary":"Hims & Hers ($HIMS) saw its partnership with Novo Nordisk come to a sudden end last month after the Danish drugmaker terminated their distribution ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/morgan-stanley-weighs-in-on-hims-stock-amid-ongoing-legal-and-regulatory-hurdles?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/morgan-stanley-weighs-in-on-hims-stock-amid-ongoing-legal-and-regulatory-hurdles?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4534","LU0314104364.USD","LU2357305700.SGD","BK4516","LU0106261372.USD","IE00BZ1G4Q59.USD","LU0320765646.SGD","LU2028103732.USD","LU0154236417.USD","LU1074936037.SGD","IE00BKVL7J92.USD","LU0006306889.USD","LU1668664300.SGD","BK4532","LU0158827948.USD","BK4588","LU0106831901.USD","LU1989772840.SGD","LU0971096721.USD","LU1093756168.USD","HIMS","BK4127","LU0234570918.USD","LU2271345857.HKD","LU2347655156.SGD","LU1093756325.SGD","LU1363072403.SGD","LU2089283258.USD","LU0795875086.SGD","LU2133065610.SGD","LU1732800096.USD","BK4007","LU0267386448.USD","BK4504","BK4585","LU1720051108.HKD","LU0158827781.USD","LU0912757837.SGD","LU1989772923.USD","LU0225283273.USD","LU0795875169.SGD","LU1720051017.SGD","LU1732799900.SGD","LU2023251221.USD","BK4599","LU1548497426.USD","BK4196","LU2111349929.HKD","BK4581"],"gpt_icon":0},{"id":"2549532487","title":"AI Analyst Remains Bullish on HIMS Stock While Wall Street Stays on the Fence","url":"https://stock-news.laohu8.com/highlight/detail?id=2549532487","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549532487?lang=en_us&edition=full_marsco","pubTime":"2025-07-07 20:37","pubTimestamp":1751891861,"startTime":"0","endTime":"0","summary":"While most of Wall Street remains cautious on Hims & Hers Health ($HIMS), TipRanks’ A.I. Stock Analysis tool continues to show confidence in the te...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ai-analyst-remains-bullish-on-hims-stock-while-wall-street-stays-on-the-fence?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ai-analyst-remains-bullish-on-hims-stock-while-wall-street-stays-on-the-fence?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4196","HIMS"],"gpt_icon":0},{"id":"2549653164","title":"Analysts Offer Insights on Healthcare Companies: KalVista Pharmaceuticals (KALV) and Hims & Hers Health (HIMS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2549653164","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549653164?lang=en_us&edition=full_marsco","pubTime":"2025-07-07 19:30","pubTimestamp":1751887812,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on KalVista Pharmaceuticals (KALV – Research Report) ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-kalvista-pharmaceuticals-kalv-and-hims-hers-health-hims-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-kalvista-pharmaceuticals-kalv-and-hims-hers-health-hims-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4196","KALV","BK4139","HIMS","HCSG","BK4137"],"gpt_icon":0},{"id":"2548887283","title":"Chief Legal Officer Soleil Boughton Reports Disposal of Common Shares of Hims & Hers Health Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2548887283","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548887283?lang=en_us&edition=full_marsco","pubTime":"2025-07-02 04:46","pubTimestamp":1751402765,"startTime":"0","endTime":"0","summary":"Soleil Boughton, Chief Legal Officer of Hims & Hers Health Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hims & Hers Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on July 01, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250701:nNDL2bpNmQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","HIMS"],"gpt_icon":1},{"id":"2547867092","title":"Hims & Hers Health Faces Challenges In Legal Minefield Over Weight-Loss Drugs -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2547867092","media":"Dow Jones","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2547867092?lang=en_us&edition=full_marsco","pubTime":"2025-06-30 21:10","pubTimestamp":1751289000,"startTime":"0","endTime":"0","summary":"0910 ET - A key question for Hims & Hers Health is whether it could continue to offer compounded treatments if a lawsuit is filed against it by Novo Nordisk, say Morgan Stanley analysts in a research note. Novo earlier this month abruptly ended its partnership with Hims & Hers after accusing it of illegally selling cheaper copycats of its Wegovy weight-loss drug and engaging in deceptive marketing. The analysts note that five of six defendants in lawsuits by Eli Lilly against compounders are continuing to offer compounded GLP-1s. Regardless, the analysts say a \"a bear-case narrative for HIMS has resurfaced,\" and they expect these developments to be an overhang on the stock into Q2 earnings. Hims & Hers sold off 23% last week, but has more than doubled so far this year. ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","LU0225283273.USD","LU1989772840.SGD","LU2357305700.SGD","LU2347655156.SGD","LU0106831901.USD","LU2089284900.SGD","LU0006306889.USD","BK4516","BK4504","BK4127","LU0106261372.USD","LU1162221912.USD","IE00BZ1G4Q59.USD","LU0158827781.USD","LU1989772923.USD","LU1732799900.SGD","LU0234570918.USD","LU0158827948.USD","LU0314104364.USD","IE00BKVL7J92.USD","LU2023251221.USD","BK4196","LU1668664300.SGD","LU2271345857.HKD","LU2111349929.HKD","HIMS","LU0267386448.USD","LU0795875169.SGD","LU1732800096.USD","BK4534","LU0971096721.USD","LU1720051017.SGD","LU0320765646.SGD","BK4585","LU1363072403.SGD","LU2089283258.USD","LU0795875086.SGD","BK4588","LU2028103732.USD","LU2133065610.SGD","LU1074936037.SGD","LU1548497426.USD","LU0098860793.USD","LU1720051108.HKD","LU0912757837.SGD"],"gpt_icon":1},{"id":"2546770014","title":"Hims & Hers Health Inc. Faces Class Action Lawsuit Over Alleged Deceptive Practices and Partnership Termination with Novo Nordisk","url":"https://stock-news.laohu8.com/highlight/detail?id=2546770014","media":"Reuters","labels":["policyRegulatory","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546770014?lang=en_us&edition=full_marsco","pubTime":"2025-06-28 21:46","pubTimestamp":1751118363,"startTime":"0","endTime":"0","summary":"Hims & Hers Health Inc. Faces Class Action Lawsuit Over Alleged Deceptive Practices and Partnership Termination with Novo Nordisk. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hims & Hers Health Inc. published the original content used to generate this news brief via Newsfile  on June 28, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250628:nNDL4jvq7S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMS","BK4196"],"gpt_icon":1},{"id":"2546291482","title":"Is the Hims & Hers Stock (HIMS) Crash a Hidden Buying Opportunity?","url":"https://stock-news.laohu8.com/highlight/detail?id=2546291482","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546291482?lang=en_us&edition=full_marsco","pubTime":"2025-06-26 05:30","pubTimestamp":1750887000,"startTime":"0","endTime":"0","summary":"Hims & Hers Health ($HIMS) stock has taken a sharp hit recently, sparking concern among investors. The stock suffered a record one-day drop of over...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/why-hims-hers-stock-hims-crash-may-be-a-bargain-in-disguise?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/why-hims-hers-stock-hims-crash-may-be-a-bargain-in-disguise?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4196","HIMS"],"gpt_icon":0},{"id":"1167390774","title":"Stock Track | Hims & Hers Health Soars 5.16% as CEO Vows to Continue Offering Low-Cost Weight-Loss Shots Despite Novo Nordisk Split","url":"https://stock-news.laohu8.com/highlight/detail?id=1167390774","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167390774?lang=en_us&edition=full_marsco","pubTime":"2025-06-25 21:36","pubTimestamp":1750858615,"startTime":"0","endTime":"0","summary":"Hims & Hers Health Inc.  shares are soaring 5.16% in pre-market trading on Wednesday, rebounding from a massive 35% plunge the previous day. The stock's recovery comes as CEO Andrew Dudum firmly stated the company's intention to continue offering low-cost weight-loss injections, despite the recent termination of its distribution partnership with Novo Nordisk.Investors appear to be responding positively to Hims & Hers Health's stance, as the company refutes Novo Nordisk's characterization of thei","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["HIMS"],"gpt_icon":1},{"id":"1159763473","title":"Hims \"Won't Cave\" to Novo Demands Over Copycat Weight-Loss Shots, CEO Says","url":"https://stock-news.laohu8.com/highlight/detail?id=1159763473","media":"Bloomberg","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159763473?lang=en_us&edition=full_marsco","pubTime":"2025-06-25 10:42","pubTimestamp":1750819327,"startTime":"0","endTime":"0","summary":"Hims & Hers Health Inc. won’t back down from selling cheap weight-loss shots, its chief executive officer said one day after Novo Nordisk A/S abruptly ended its distribution partnership.“We’re upset t","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.bloomberg.com/news/articles/2025-06-24/hims-won-t-cave-to-novo-demands-over-copycat-shots-ceo-says","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Hims \"Won't Cave\" to Novo Demands Over Copycat Weight-Loss Shots, CEO Says","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lsy1584095487587","symbols":["HIMS","NVO"],"gpt_icon":1},{"id":"2546253646","title":"CFO Oluyemi Okupe Reports Disposal of Common Shares in Hims & Hers Health Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2546253646","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546253646?lang=en_us&edition=full_marsco","pubTime":"2025-06-25 04:32","pubTimestamp":1750797134,"startTime":"0","endTime":"0","summary":"Oluyemi Okupe, Chief Financial Officer of Hims & Hers Health Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hims & Hers Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 24, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250624:nNDLbGCnJJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"CFO Oluyemi Okupe Reports Disposal of Common Shares in Hims & Hers Health Inc","news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","HIMS"],"gpt_icon":1},{"id":"2546237810","title":"Morgan Stanley Keeps Their Hold Rating on Hims & Hers Health (HIMS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2546237810","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546237810?lang=en_us&edition=full_marsco","pubTime":"2025-06-25 01:35","pubTimestamp":1750786518,"startTime":"0","endTime":"0","summary":"Morgan Stanley analyst Craig Hettenbach reiterated a Hold rating on Hims & Hers Health (HIMS – Research Report) yesterday and set a price target of...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/morgan-stanley-keeps-their-hold-rating-on-hims-hers-health-hims-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/morgan-stanley-keeps-their-hold-rating-on-hims-hers-health-hims-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HIMS"],"gpt_icon":0},{"id":"2545236087","title":"Hims & Hers Health (HIMS) Gets a Hold from Deutsche Bank","url":"https://stock-news.laohu8.com/highlight/detail?id=2545236087","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545236087?lang=en_us&edition=full_marsco","pubTime":"2025-06-24 22:45","pubTimestamp":1750776306,"startTime":"0","endTime":"0","summary":"In a report released today, George Hill from Deutsche Bank reiterated a Hold rating on Hims & Hers Health (HIMS – Research Report), with a price ta...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/hims-hers-health-hims-gets-a-hold-from-deutsche-bank-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/hims-hers-health-hims-gets-a-hold-from-deutsche-bank-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","BK4566","BK4196","DB","BK4118","MMAT","HIMS","BK4552","BK4141"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0019},{"period":"1month","weight":-0.168},{"period":"3month","weight":0.7587},{"period":"6month","weight":0.8847},{"period":"1year","weight":1.2751},{"period":"ytd","weight":0.9806}],"compareEarnings":[{"period":"1week","weight":-0.0028},{"period":"1month","weight":0.037},{"period":"3month","weight":0.168},{"period":"6month","weight":0.0743},{"period":"1year","weight":0.1207},{"period":"ytd","weight":0.0641}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.14307},{"month":2,"riseRate":0.666667,"avgChangeRate":0.154354},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.058791},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.029824},{"month":5,"riseRate":0.5,"avgChangeRate":0.191652},{"month":6,"riseRate":0.666667,"avgChangeRate":-0.021115},{"month":7,"riseRate":0.5,"avgChangeRate":0.012088},{"month":8,"riseRate":0.4,"avgChangeRate":-0.10346},{"month":9,"riseRate":0.4,"avgChangeRate":0.028662},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.052391},{"month":11,"riseRate":0.833333,"avgChangeRate":0.240153},{"month":12,"riseRate":0.5,"avgChangeRate":0.028825}],"exchange":"NYSE","name":"Hims & Hers Health Inc.","nameEN":"Hims & Hers Health Inc."},"APP":{"userAgent":"CCBot/2.0 (https://commoncrawl.org/faq/)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Hims & Hers Health Inc.(HIMS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Hims & Hers Health Inc.(HIMS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Hims & Hers Health Inc.,HIMS,Hims & Hers Health Inc.股票,Hims & Hers Health Inc.股票老虎,Hims & Hers Health Inc.股票老虎国际,Hims & Hers Health Inc.行情,Hims & Hers Health Inc.股票行情,Hims & Hers Health Inc.股价,Hims & Hers Health Inc.股市,Hims & Hers Health Inc.股票价格,Hims & Hers Health Inc.股票交易,Hims & Hers Health Inc.股票购买,Hims & Hers Health Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Hims & Hers Health Inc.(HIMS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Hims & Hers Health Inc.(HIMS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}